An NHS initiative designed to purge so-called “ghost patients” from general practitioner registers is disproportionately affecting some of England’s most disadvantaged communities, according to new analysis.
Previously, patients at risk of being struck off following prolonged inactivity were given a six-month window to respond to outreach efforts. However, NHS England’s accelerated list-validation programme, launched last October, has cut that response period to just three months.
Data compiled by Healthtech-1 reveals that registered patient counts across English GP practices fell by 483,019 between October 2025 and July 2026. Practices in the most deprived quintile accounted for approximately 138,400 of that net reduction — nearly 30 per cent of the national total.
Although GP lists require periodic review as patients relocate or pass away, clinicians say the compressed timeline has resulted in sizable numbers of vulnerable individuals being erroneously removed, effectively blocking their access to care.
As a consequence, GPs and practice managers have been forced to manually re-register affected patients, placing a significant additional administrative strain on already stretched practices.
Removing patients from registers also disrupts continuity of care and ongoing treatment. Because GP practice funding is partly tied to patient list size, a sharp decline can jeopardise the ability to cover operational costs.
A GP at a university-affiliated practice in Southampton described mounting problems as patients are removed in error and subsequently lose access to prescriptions and ongoing treatment.
“If you issue repeat prescriptions, they are ongoing, and once someone is struck off the register they can no longer collect any medication,” he explained. “The danger is that if people cannot access their repeat prescriptions, their overall treatment suffers.”
He added: “Compressing the window from six months to three months means more people will be removed and, as a result, more people will find themselves unable to access treatment.”
The GP also cautioned that, in addition to reducing practice income, the policy change is having the harshest impact on patients from deprived and vulnerable backgrounds.
“In our case, approximately 100 patients were taken off our list despite not having moved at all. That represented roughly £10,000 in lost revenue for our practice,” he said.
“We were later contacted by these patients, who told us they could no longer access their prescriptions and that they had not moved away.”
“The money we’ve lost has not been reimbursed, and I’m aware of another local practice that has lost £100,000 and will also receive no compensation.”
“Those who have been wrongly taken off are being penalised. We will have to make cuts somewhere to cover the shortfall.”
Dr Clare Bannon, chair of the British Medical Association’s GP committee, said GPs throughout England support the principle of maintaining accurate patient lists but argue the current cleansing process is “seriously flawed”.
Bannon stated: “We have urged NHS England to pause the exercise. The approach is too aggressive, resulting in practices losing tens of thousands of pounds in income and causing active patients — including vulnerable individuals — to be removed in error.”
“It is essential that active patients are not denied access to a GP through no fault of their own.”
An NHS spokesperson said: “Robust safeguards are in place to ensure vulnerable groups are not removed from GP lists. People are contacted through multiple channels, and thorough processes last up to five months before any action is taken.”
“This process ensures patient contact details are accurate so they receive vital information about screening and vaccination appointments, while also ensuring NHS funding is allocated fairly and money is not spent on individuals who no longer reside in England.”
Also Read
- STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
- Tacabrutideg: A Novel BTK Degrader Reshaping the Treatment Landscape for B-Cell Malignancies
- Prostate Protein PSA Linked to Rare Semen Allergy Through Cross-Reactive Dog Antigen
- Pelago Launches Integrated Behavioral Health Platform for Comprehensive Substance Use, Mental Health, and Addiction Treatment


